Kidney stones: pathophysiology and medical management

被引:671
作者
Moe, OW [1 ]
机构
[1] Univ Texas, SW Med Ctr, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
关键词
D O I
10.1016/S0140-6736(06)68071-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The formation of stones in the urinary tract stems from a wide range of underlying disorders. That clinicians look for the underlying causes for nephrolithiasis is imperative to direct management. There are many advances in genetics, pathophysiology, diagnostic imaging, medical treatment, medical prevention, and surgical intervention of 14 nephrolithiasis. Here, I provide a brief general background and focus mainly on pathophysiology and medical treatment of kidney stones. Although important advances have been made in understanding nephrolithiasis from single gene defects, the understanding of polygenetic causes of kidney stones is still largely elusive. A substantial proportion of data that resulted in new methods of treatment and prevention, which can be empirical or definitive, has focused on urinary luminal chemical composition of the precipitating solutes. Manipulation of inhibitors and epithelial factors is important and needs further investigation. Advances in the management of nephrolithiasis depend on combined efforts of clinicians and scientists to understand the pathophysiology.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 138 条
  • [1] The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance
    Abate, N
    Chandalia, M
    Cabo-Chan, AV
    Moe, OW
    Sakhaee, K
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (02) : 386 - 392
  • [2] The clinical spectrum of chronic metabolic acidosis: Homeostatic mechanisms produce significant morbidity
    Alpern, RJ
    Sakhaee, K
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) : 291 - 302
  • [3] Effect of high protein diet on stone-forming propensity and bone loss in rats
    Amanzadeh, J
    Gitomer, WL
    Zerwekh, JE
    Preisig, PA
    Moe, OW
    Pak, CYC
    Levi, M
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (06) : 2142 - 2149
  • [4] Hyperoxaluric calcium nephrolithiasis
    Asplin, JR
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2002, 31 (04) : 927 - +
  • [5] Surgical management of urolithiasis
    Auge, BK
    Preminger, GM
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2002, 31 (04) : 1065 - +
  • [6] Bagley Demetrius H, 2002, Curr Opin Urol, V12, P277, DOI 10.1097/00042307-200207000-00003
  • [7] Risk of cancer from diagnostic X-rays:: estimates for the UK and 14 other countries
    Berrington de González, A
    Darby, S
    [J]. LANCET, 2004, 363 (9406) : 345 - 351
  • [8] BICHLER KH, 1985, MONATSSCHR KINDERH, V133, P256
  • [9] Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features
    Bilezikian, JP
    Brandi, ML
    Rubin, M
    Silverberg, SJ
    [J]. JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) : 6 - 17
  • [10] Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study
    Borghi, L
    Meschi, T
    Amato, F
    Briganti, A
    Novarini, A
    Giannini, A
    [J]. JOURNAL OF UROLOGY, 1996, 155 (03) : 839 - 843